INTRODUCTION
Kallmann syndrome (OMIM #308700) is a congenital cause of delayed puberty and infertility, classically characterized by the accompanying symptom of anosmia or hyposmia (Kim, 2015) . The syndrome was first described as early as 1856 and named by the German neuropathologist Franz Josef Kallmann, who identified an X-linked inheritance pattern in 1944 (Kallmann et al., 1944) . It was clinically defined as hypogonadotropic hypogonadism with anosmia (Dod e & Hardelin, 2009) . Later discoveries led to a better understanding of the pathogenesis of the disease, caused by a defect of the migration of gonadotropin-releasing hormone (GnRH) neurons during embryonic development. Later in life, this can be observed with MRI as hypoplasia or aplasia of the olfactory bulb and a spectrum of morphologic changes in the basal forebrain cortex (Manara et al., 2014) . This deficit in GnRH leads to a failure of the hypothalamic-hypophysiary axis and a deficit of the subsequent downstream gonadotropins that would otherwise trigger the start of puberty (Kim, 2015) . Patients most often seek medical care with an initial complaint of delayed onset of puberty. Clinical diagnosis is made when delayed puberty presents accompanied by anosmia and after laboratory confirmation of low values of testosterone, luteinizing hormone (LH), and follicle stimulating hormone (FSH) (Gonc ßalves et al., 2017) .
Kallmann syndrome is a rare disease, with an incidence of 1 in 8000 males and 1 in 40,000 females (Dod e & Hardelin, 2010) . Approximately two-thirds of the cases present as familial syndromes, the remaining constitutes sporadic cases (Hamada et al., 2013) . Despite Kallmann syndrome being one of the most common causes of hypogonadal hypogonadism, the genetic cause is identified in only 50% of familial cases and 10% of sporadic ones (Hamada et al., 2013) . Disease-causing variants in more than 30 genes have been described as causes of Kallmann syndrome (Quaynor et al., 2016) , in several different inheritance patterns including not only X-linked, but also autosomal dominant and recessive pathogenic variants (Layman, 2013) . This fact determines the importance of identifying new genetic causes, to provide an accurate genetic diagnosis and refer these patients to the appropriate treatment and genetic counseling for their healthcare needs. It also accounts for the need for sequencing tools that can address genetically heterogeneneous causes, such as whole exome sequencing.
In this study, we looked for the genetic alterations in two brothers with a clinical diagnosis of Kallmann syndrome. We examined all coding genetic variants with whole exome sequencing. Our findings provide evidence on the value of whole exome sequencing in the search for causative variants in a genetically heterogenous condition.
MATERIALS AND METHODS

Patient ascertainment
Two male siblings with a clinical diagnosis of Kallmann syndrome referred to our institution for an andrology consultation. Approval for this study was obtained through our Institutional Review Board (research project number 20150740). All participants provided written informed consent, and the study was performed in accordance to the World Medical Association's Declaration of Helsinki (Association, 2014).
Whole exome sequencing
DNA was extracted from peripheral blood from the two brothers and their mother using the commercial kit QIAamp blood maxi (Qiagen, Germantown, MD, USA). Whole exome sequenced was performed at the John P. Hussman Institute for Human Genomics at the University of Miami. There, 3 lg of DNA from each the brothers was prepared using the SureSelect Human All Exon V6 (Agilent, Santa Clara, CA). Resulting libraries were sequenced on an Illumina HiSeq 2500 (Illumina, San Diego, CA) for 50 million paired end 100-bp reads according to published protocols (Chen et al., 2015) .
Data analysis
DNA reads were processed according to Genome Analysis Toolkit (GATK) best practices guidelines (McKenna et al., 2010 , DePristo et al., 2011 Van der Auwera et al., 2013) . Briefly, reads were aligned to the human GRCh37 genome with BWA-MEM (Li, 2013) . Aligning sequence reads, clone sequences, and assembly contigs with BWA-MEM. (arXiv:1303.3997v1 [q-bio.GN]) duplicates marked with Picard (http://broadinstitute.github.io/ picard) and base-quality recalibration was performed by GATK. DNA variants were called with the GATK HaplotypeCaller for each sample. Variants were filtered for sites at a minimum depth of 8X, alternate allele fraction >0.3, and alternate genotype likelihood (PL score) >100. We used the Feb2017 version of ANNO-VAR (Wang et al., 2010) for annotation against the RefGene transcript model. Information regarding population frequency was added from the Exome Variant Server (EVS) (URL: http:// evs.gs.washington.edu/EVS/) [accessed April 2017], 1000 Genomes project (Auton et al., 2015) , and the Exome Aggregation Consortium (Lek et al., 2016) .
Variants were interpreted as pathogenic or likely pathogenic according to the American College of Medical Genetics and the Association for Molecular Pathology guidelines (Richards et al., 2015) , prioritized by being shared in both brothers, present in protein coding regions or within 20 bp of introns, and introducing nonsense, frameshift, splicing or non-synonymous amino acid changes. These variants were compared to population frequencies in the public databases and filtered for those present at less than 1% in overall population, or not reported the aforementioned databases (EVS, 1000 Genomes Project and ExAC). Validation of identified likely pathogenic variant was performed by targeted Sanger sequencing (GENEWIZ (http://www.genewiz.c om)) of the surrounding 378 base pairs in the variant of 
RESULTS
Case report
The proband in this study was a 23-year-old male referred to our Andrology Department by an endocrinologist, whom he consulted initially because of symptoms of delayed puberty. The patient had a past medical history of undescended testicles. On physical exam, patient showed Tanner developmental stage II, and 2 cc testes bilaterally. He denied symptoms of lack of energy or erectile dysfunction. He did endorse absence of sex drive, but was not interested in his fertility evaluation and refused to provide a semen analysis. Blood tests found testosterone in the lower end of normal range (264 ng/dL total; 56 pg/mL total), and low LH and FSH levels (0.3 and 0.7 mIU/mL respectively).
His younger 21-year-old brother showed normal pubertal development at clinical examination except for decreased testicular size (2 cc bilaterally). He denied symptoms of testosterone deficiency such as asthenia or decreased libido. His blood tests, however, showed low levels of testosterone (133 ng/dL total, 28.9 pg/mL free) and undetectable levels of LH. Additionally, semen analysis revealed azoospermia. To stimulate spermatogenesis, he was placed on human chorionic gonadotropin therapy (2000 international units subcutaneously every other day). Concurrently, both brothers were placed on testosterone replacement therapy (200 mg testosterone monthly injections). Of note, both patients complained of anosmia and were unable to identify coffee by smell.
Whole exome results
Whole exome sequencing identified a total of 117,841 single nucleotide variants (SNVs) and small insertion-deletions (indels) with variation in at least one of the two brothers (Table 1) . Of the shared identical genotypes in 59,711 positions, filtering for putatively functional coding variants revealed 15,713 exonic variants. These exonic variants comprised 8,076 synonymous or non-frameshift alterations, 7302 non-synonymous SNVs, and 335 likely gene disrupting events (frameshift indels, stop gains, stop losses or splice site alterations). We expected that the underlying causative variant would be shared by the brothers, missense, or gene disrupting, and should be rare in the overall population. Thus, we further applied filtering criteria that required both brothers to be sharing a variant and with less than 1% frequency in the EVS, 1000 Genomes, and ExAC database. Only five variants met all of these criteria and contained in the genes ANOS1, HRNR, SLC6A6, LINC00649, and MAGEE2. Among the five candidate variants, we identified an G>A variant at chrX:8522080. This induces a c.1267C>T change in ANOS1 causing a p.R423* premature stop codon in exon 9 likely causing production of a truncated anosmin1 (NM_000216.3). The presence of this hemizygous variant was confirmed in both brothers and heterozygous in their mother by Sanger sequencing at GEN-EWIZ (http://www.genewiz.com) (Figure 1 ). This variant is not reported in the three genomic databases studied, but has been found associated with Kallmann syndrome twice in the literature (Jiang et al., 2013; Fan et al., 2017) . Therefore, we conclude that this is a pathogenic variant according to American College of Medical Genetics guidelines and the cause of Kallmann syndrome in this family.
DISCUSSION
ANOS1 on chromosome X is the gene more frequently altered and was formerly named KAL1 (Kallmann 1) (de Castro et al., 2016) . Studies on different phenotypes of hypogonadotropic hypogonadism have linked up to 7.1% of the cases to pathogenic variants of ANOS1 (Dod e & Hardelin, 2009), which accounts for 30-60% of familial and 10-15% of the sporadic Kallmann syndrome cases with known genetic causes (Hamada et al., 2013) . The main benefit of using WES lies in the hability to identify new variations in multiple genes at a time. In this case, the remaining candidate variants were less likely to cause our patients' phenotype: LINC00649 codifies for non-protein-producing RNA; pathogenic variants of the chlorine-transporter encoded by SLC6A6 cause a very different phenotype with deeply impaired cerebral and muscular function; HRNR contributes to intermediate filaments in the skin epithelium and immunologic system; and MAGEE2 is a melanoma-associated protein, only expressed in tumors and male gonadal tissue (www.genecards.org; Chomez et al., 2001; Fishilevich et al., 2016) .
The product of this gene, anosmin1, is a cellular adhesion protein with several roles in the development of the central nervous system, including axon pathfinding, cell motility, and cell migration. During normal embryologic development, GnRH neurons migrate from the olfactory plate in the nose to the hypophysis in the brain, following the pathway of the olfactory nerve fibers. Some variants of ANOS1 disrupt this process, thus causing Kallmann syndrome (Hu et al., 2003) . Other alterations of ANOS1 have been found associated with other conditions inside and outside the central nervous system, such as multiple sclerosis and atopic dermatitis (de Castro et al., 2014) .
The studied patients present different degrees of the classic Kallmann phenotype with delayed puberty and infertility due to hypogonadal hypogonadism. There are, however, other less frequent features associated with Kallmann syndrome. These include cryptorchidism, renal and dental agenesis (Layman, 2013) , and other less evident malformations of the urinary tract, such as duplicated ureter, hydronephrosis, and horseshoe kidney. Many of these alterations have been found more frequently present in those patients with Kallmann syndrome caused by X-linked genetic alterations (El Husny et al., 2014) . This provides another reason for the importance of accurate genetic diagnosis, as urinary evaluation and sometimes abdominal ultrasound should be considered in some of these patients. In the cases presented here, the older brother underwent evaluation in his childhood. He was diagnosed and treated for cryptorchidism. For the younger brother, further evaluation was not indicated because of the lack of urinary symptoms and bilaterally descended testes. We were unable to obtain generational information beyond the parents, which constitutes a limitation to our study. Patients and their parents did however not recall any family history of infertility or anosmia at anamnesis.
The identified c.1267C>T variant in ANOS1 in this study has been reported twice before in the literature. Its first description was in a patient with clinical hypogonadotropic hypogonadism who also had a diagnosis of autism spectrum disorder (ASD) at age 14. This leads the authors to hypothesize a possible causality between the variant and ASD, given the role of anosmin in neurodevelopment (Jiang et al., 2013) . It was subsequently reported in a study performing next-generation sequencing of genes associated with disorders of sexual development (DSD) to identify novel disease-causing variants. In this study, there were four patients with clinical hypogonadotropic hypogonadism and one was identified to have the c.1267C>T variant in ANOS1 (Fan et al., 2017) . Although our patients may fit into the spectrum of DSD, none of them fulfilled diagnostic criteria for autism on evaluation. Our analysis included filtering for homozygous or hemizygous variants. Some variants have been reported to cause Kallmann syndrome in autosomal dominant inheritance pattern, thus placing as limitation of our study the potential for omission of those causing variants. However, the presence of the c.1267C>T variant in at least two previously reported patients with clinical hypogonadotropic hypogonadism further validates that this variant is truly pathogenic and validates the WES variant calling, annotation and filtering protocol we use in this study.
Gonadotropin and testicular function have been described to recover spontaneously, partially or completely, in up to 10% of cases of Kallmann syndrome (Maione et al., 2016) . However, in most, this will be achieved through hormone replacement therapy. For this purpose, early diagnosis and establishment of the appropriate treatment are essential: Testosterone deficiency not only places a physical health risk due to osteopenia, anemia, and metabolic syndrome (Lunenfeld et al., 2015) , but delayed puberty, lack of sexual drive, and infertility are important causes of emotional distress and can lead the patients to social isolation from their peers (Smith & Quinton, 2012) .
With the use of whole exome sequencing, we have identified a pathogenic variant of ANOS1, present in two brothers with Kallmann syndrome and heterozygous in their mother. Although there are more than 140 variants identified in ANOS1 as causes of Kallmann syndrome, this variant has been previously reported only in two cases. Genetic testing provides confirmatory diagnosis and allows the establishment of the appropriate therapy. Additionally, it has another valuable application for those patients able to produce spermatozoa and wanting to have children: The knowledge of their pathogenic variants is the cornerstone of genetic counseling and opens the possibility for preimplantation diagnosis. This can ensure that their genetic alterations are not transmitted to the following generation. In a case like this of an X-linked disease, this can be performed simply by selecting female embryos for implantation.
CONCLUSION
Using whole exome sequencing, we identified a rare variant in ANOS1 as the cause of Kallmann syndrome in two brothers. This result supports the clinical value of WES for the identification of genetic variants with pathogenic potential and further validates the establishment of clinical diagnoses with genetic and molecular tools.
Kallmann syndrome is an important cause of infertility and delayed puberty in the pediatric population. Identification of disease-causing variants is the first, essential step for genetic counseling and preimplantation diagnosis. These tools are of invaluable help for the affected patients and their parents, as they can allow them to have children free of the disease-causing genetic alterations.
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